Health Condition 1: A499- Bacterial infection, unspecified
Conditions
Interventions
Intervention1: 5 ml whole blood will be taken from the patient: 5 ml whole blood will be taken from the patient for the purpose of serum procalcitonin estimation. The test for presepsin and PTX-3 will
Sponsors
AIIMS JODHPUR
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients having clinical features suggestive of sepsis
Exclusion criteria
Exclusion criteria: Exclusion criteria are age < 18 years, patients with terminal stage of disease (malignant cancer of any type, acquired immunodeficiency syndrome, end-stage liver or renal disease) patient who have received antibiotics and patient/relatives who will not consent to inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study Changes in Pentraxin-3 and Presepsin levels in patients with sepsis during first week of ICU admissionTimepoint: Day 1 3 7 death or discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To study the utility of Pentraxin-3 and Presepsin with prognosis of sepsis using sequential organ failure assessment (SOFA) score 2. To study the sensitivity and specificity of Pentraxin-3 and Presepsin for 28 day mortality in critically ill patients 3. To compare Pentraxin-3 and Presepsin with Procalcitonin in ICU patients with sepsis Timepoint: Day 1 3 7 28 death or discharge | — |
Countries
India
Contacts
Public ContactDr Ankur Sharma
AIIMS JODHPUR
Outcome results
None listed